← Alle Unternehmen
Über das Unternehmen
At Qnomx, we are transforming cancer genomic data interpretation to optimize therapy selection in oncology. Our QNOMX platform empowers labs to automate the final manual review of genomic profiles and streamline the genetic testing workflow, enhance efficiency, reduce costs, and increase productivity, ultimately accelerating the time from genomic testing to treatment decisions and improving the quality of those decisions.